Nutr Res Pract.  2015 Feb;9(1):22-29. 10.4162/nrp.2015.9.1.22.

Anti-diabetic effect of purple corn extract on C57BL/KsJ db/db mice

Affiliations
  • 1College of Food Science and Engineering, Liaoning Medical University, Jinzhou 121000, China.
  • 2Institute of Natural Medicine, Hallym University Medical School, Gangwon 200-702, Korea. limss@hallym.ac.kr
  • 3Department of Food Science and Nutrition and Center for Aging and HealthCare, Hallym University, 1 Hallymdaehak-gil, Chuncheon, Gangwon 200-702, Korea.
  • 4Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University, Gangwon 200-702, Korea.
  • 5Department of Biochemistry, School of Medicine, Hallym University, Gangwon 200-702, Korea.

Abstract

BACKGROUND/OBJECTIVES
Recently, anthocyanins have been reported to have various biological activities. Furthermore, anthocyanin-rich purple corn extract (PCE) ameliorated insulin resistance and reduced diabetes-associated mesanginal fibrosis and inflammation, suggesting that it may have benefits for the prevention of diabetes and diabetes complications. In this study, we determined the anthocyanins and non-anthocyanin component of PCE by HPLC-ESI-MS and investigated its anti-diabetic activity and mechanisms using C57BL/KsJ db/db mice.
MATERIALS/METHODS
The db/db mice were divided into four groups: diabetic control group (DC), 10 or 50 mg/kg PCE (PCE 10 or PCE 50), or 10 mg/kg pinitol (pinitol 10) and treated with drugs once per day for 8 weeks. During the experiment, body weight and blood glucose levels were measured every week. At the end of treatment, we measured several diabetic parameters.
RESULTS
Compared to the DC group, Fasting blood glucose levels were 68% lower in PCE 50 group and 51% lower in the pinitol 10 group. Furthermore, the PCE 50 group showed 2- fold increased C-peptide and adiponectin levels and 20% decreased HbA1c levels, than in the DC group. In pancreatic islets morphology, the PCE- or pinitol-treated mice showed significant prevention of pancreatic beta-cell damage and higher insulin content. Microarray analyses results indicating that gene and protein expressions associated with glycolysis and fatty acid metabolism in liver and fat tissues. In addition, purple corn extract increased the phosphorylation of AMP-activated protein kinase (AMPK) and decreased phosphoenolpyruvate carboxykinase (PEPCK), glucose 6-phosphatase (G6pase) genes in liver, and also increased glucose transporter 4 (GLUT4) expressions in skeletal muscle.
CONCLUSIONS
Our results suggested that PCE exerted anti-diabetic effects through protection of pancreatic beta-cells, increase of insulin secretion and AMPK activation in the liver of C57BL/KsJ db/db mice.

Keyword

Purple corn; diabetes; insulin; microarray assay; AMPK

MeSH Terms

Adiponectin
AMP-Activated Protein Kinases
Animals
Anthocyanins
Blood Glucose
Body Weight
C-Peptide
Diabetes Complications
Fasting
Fibrosis
Glucose Transport Proteins, Facilitative
Glucose-6-Phosphatase
Glycolysis
Inflammation
Insulin
Insulin Resistance
Islets of Langerhans
Liver
Metabolism
Mice*
Muscle, Skeletal
Phosphoenolpyruvate
Phosphorylation
Zea mays*
AMP-Activated Protein Kinases
Adiponectin
Anthocyanins
Blood Glucose
C-Peptide
Glucose Transport Proteins, Facilitative
Glucose-6-Phosphatase
Insulin
Phosphoenolpyruvate

Figure

  • Fig. 1 HPLC chromatography of major components of PCE. Non-anthocyanins (A) and anthocyanins (B) were detected at 280 nm and 570 nm, respectively.

  • Fig. 2 Oral glucose tolerance test (A) after 12 h of food deprivation in db/db mice. (B) Area under the blood-glucose concentration curve was measured over the next 120 min (AUC-120 min). Values represent mean ± SE (n = 6). *P < 0.05 vs. Cont.

  • Fig. 3 Microscopic view of pancreas sections and immunostaining of insulin Control, PCE 10, PCE 50 and pinitol 10 group. H & E, magnification × 200.

  • Fig. 4 Effects of PCE on phosphorylations of hepatic AMPK and ACC protein (A), PEPCK, G6pase, or GLUT4 (B) mRNA levels in liver, muscle. The amount of RNA loaded in each lane was confirmed by RT-PCR of CPN or Actin mRNA.


Reference

1. Vinik AI, Vinik E. Prevention of the complications of diabetes. Am J Manag Care. 2003; 3:S63–S80.
2. Goldfrank L, Lewin N, Flomenbaum N, Howland MA. The pernicious panacea: herbal medicine. Hosp Physician. 1982; 10:64–69.
3. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care. 1989; 8:553–564.
Article
4. Jing P, Giusti MM. Characterization of anthocyanin-rich waste from purple corncobs (Zea mays L.) and its application to color milk. J Agric Food Chem. 2005; 22:8775–8781.
Article
5. Fossen T, Slimestad R, Andersen OM. Anthocyanins from maize (Zea mays) and reed canarygrass (Phalaris arundinacea). J Agric Food Chem. 2001; 5:2318–2321.
Article
6. Hagiwara A, Miyashita K, Nakanishi T, Sano M, Tamano S, Kadota T, Koda T, Nakamura M, Imaida K, Ito N, Shirai T. Pronounced inhibition by a natural anthocyanin, purple corn color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in male F344 rats pretreated with 1,2-dimethylhydrazine. Cancer Lett. 2001; 1:17–25.
Article
7. Tsuda T, Horio F, Osawa T. Dietary cyanidin 3-O-beta-D-glucoside increases ex vivo oxidation resistance of serum in rats. Lipids. 1998; 6:583–588.
8. Tsuda T, Shiga K, Ohshima K, Kawakishi S, Osawa T. Inhibition of lipid peroxidation and the active oxygen radical scavenging effect of anthocyanin pigments isolated from Phaseolus vulgaris L. Biochem Pharmacol. 1996; 7:1033–1039.
Article
9. Yoshimoto M, Okuno S, Yoshinaga M, Yamakawa O, Yamaguchi M, Yamada J. Antimutagenicity of sweetpotato (Ipomoea batatas) roots. Biosci Biotechnol Biochem. 1999; 3:537–541.
Article
10. Li J, Lim SS, Lee JY, Kim JK, Kang SW, Kim JL, Kang YH. Purple corn anthocyanins dampened high-glucose-induced mesangial fibrosis and inflammation: possible renoprotective role in diabetic nephropathy. J Nutr Biochem. 2012; 4:320–331.
Article
11. Tsuda T, Horio F, Uchida K, Aoki H, Osawa T. Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr. 2003; 7:2125–2130.
12. Trinder P. Determination of blood glucose using an oxidaseperoxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969; 2:158–161.
Article
13. Goldstein BJ. Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol. 2002; 90:3G–10G.
Article
14. Liu F, Kim J, Li Y, Liu X, Li J, Chen X. An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J Nutr. 2001; 9:2242–2247.
Article
15. Guo H, Guo J, Jiang X, Li Z, Ling W. Cyanidin-3-O-b-glucoside, a typical anthocyanin, exhibits antilipolytic effects in 3T3-L1 adipocytes during hyperglycemia: Involvement of FoxO1-mediated transcription of adipose triglyceride lipase. Food chem Toxicol. 2012; 9:3040–3047.
16. Zhao X, Corrales M, Zhang C, Hu X, Ma Y, Tauscher B. Composition and thermal stability of anthocyanins from chinese purple corn (Zea mays L.). J Agric Food Chem. 2008; 22:10761–10766.
Article
17. Libby P, Plutzky J. Diabetic macrovascular disease: the glucose paradox? Circulation. 2002; 22:2760–2763.
18. Nishina PM, Naggert JK, Verstuyft J, Paigen B. Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism. 1994; 5:554–558.
Article
19. Narayanan CR, Joshi DD, Mudjumdar AM, Dhekne VV. Pinitol, a new anti-diabetic compound from the leaves of Bougainvillea spectabilis. Curr Sci. 1987; 56:139–141.
20. Hong S, Heo J, Kim J, Kwon S, Yeo K, Bakowska-Barczak A, Kolodziejczyk P, Ryu O, Choi M, Kang Y, Lim S, Suh H, Huh S, Lee J. Antidiabetic and Beta Cell-Protection Activities of Purple Corn Anthocyanins. Biomol Ther (Seoul). 2013; 21:284–289.
Article
21. Alberti KG, Zimmet PZ. New diagnostic criteria and classification of diabetes--again? Diabet Med. 1998; 7:535–536.
Article
22. Scott DK, O'Doherty RM, Stafford JM, Newgard CB, Granner DK. The repression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism. J Biol Chem. 1998; 37:24145–24151.
Article
23. Bressler R, Brendel K. The role of carnitine and carnitine acyltransferase in biological acetylations and fatty acid synthesis. J Biol Chem. 1966; 17:4092–4097.
Article
24. Kelly DP, Gordon JI, Alpers R, Strauss AW. The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase. J Biol Chem. 1989; 32:18921–18925.
25. Ling B, Aziz C, Alcorn J. Systematic Evaluation of Key L-Carnitine Homeostasis Mechanisms during Postnatal Development in Rat. Nutr Metab (Lond). 2012; 1:66.
Article
26. Nemali MR, Usuda N, Reddy MK, Oyasu K, Hashimoto T, Osumi T, Rao MS, Reddy JK. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res. 1988; 18:5316–5324.
27. Tsuchida T, Fukuda S, Aoyama H, Taniuchi N, Ishihara T, Ohashi N, Sato H, Wakimoto K, Shiotani M, Oku A. MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice. Lipids Health Dis. 2012; 11:75.
Article
28. Jiang Z, Michal JJ, Chen J, Daniels TF, Kunej T, Garcia MD, Gaskins CT, Busboom JR, Alexander LJ, Wright RW Jr, Macneil MD. Discovery of novel genetic networks associated with 19 economically important traits in beef cattle. Int J Biol Sci. 2009; 6:528–542.
Article
29. Wu XL, Macneil MD, De S, Xiao QJ, Michal JJ, Gaskins CT, Reeves JJ, Busboom JR, Wright RW Jr, Jiang Z. Evaluation of candidate gene effects for beef backfat via Bayesian model selection. Genetica. 2005; 1:103–113.
Article
30. Hardie DG. The AMP-activated protein kinase pathway--new players upstream and downstream. J Cell Sci. 2004; 23:5479–5487.
31. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 2007; 3:328–341.
Article
32. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci. 1999; 1:22–25.
Article
33. Rutter GA, Da Silva Xavier G, Leclerc I. Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J. 2003; 1:1–16.
Article
34. Velasco G, Geelen MJ, Guzmán M. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch Biochem Biophys. 1997; 2:169–175.
Article
35. Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol. 1997; 1:E1107–E1112.
Full Text Links
  • NRP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr